Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents. Its structure supports the creation of compounds with neurological activity, including potential antipsychotic or antidepressant effects. The presence of the trifluoromethyl and benzyl groups enhances metabolic stability and binding affinity in drug candidates. Commonly employed in medicinal chemistry for optimizing lead compounds in neuropharmacology.